XML 64 R24.htm IDEA: XBRL DOCUMENT v3.20.1
Note 16 - Stock-Based Compensation
12 Months Ended
Dec. 31, 2019
Notes to Financial Statements  
Stock-Based Compensation

Note 16. Stock-Based Compensation

The Company’s Board of Directors adopted in January 2008, and the stockholders approved in May 2008, the QCR Holdings, Inc. 2008 Equity Incentive Plan (“2008 Equity Incentive Plan”). The Company’s Board of Directors adopted in February 2010, and the stockholders approved in May 2010, the QCR Holdings, Inc. 2010 Equity Incentive Plan (“2010 Equity Incentive Plan”). The Company’s Board of Directors adopted in February 2013, and the stockholders approved in May 2013, the QCR Holdings, Inc. 2013 Equity Incentive Plan (“2013 Equity Incentive Plan”). The Company’s Board of Directors adopted in February 2016, and the stockholders approved in May 2016, the QCR Holdings, Inc. 2016 Equity Incentive Plan (“2016 Equity Incentive Plan”). Up to 250,000,  350,000,  350,000, and 400,000 shares of common stock, respectively, may be issued to employees and directors of the Company and its subsidiaries pursuant to equity incentive awards granted under these plans.

The 2008 Equity Incentive Plan, the 2010 Equity Incentive Plan, the 2013 Equity Incentive Plan, and the 2016 Equity Incentive Plan (collectively, the “Equity Plans”) are administered by the Compensation Committee of the Board of Directors (the “Committee”). As of December 31, 2019, there were 219,305 remaining shares of common stock available for the grant of future awards under the Equity Plans; however, such future awards may be granted only under the 2016 Equity Incentive Plan.

The number and exercise price of options granted under the Equity Plans are determined by the Committee at the time the option is granted. In no event can the exercise price be less than the value of the common stock at the date of the grant for stock options. All options have a 10‑year life and will vest and become exercisable from 3‑to‑7 years after the date of the grant.

Stock-based compensation expense was reflected in the Consolidated Financial Statements as follows for the years ended December 31, 2019, 2018, and 2017.

 

 

 

 

 

 

 

 

 

 

 

    

2019

    

2018

    

2017

 

 

(dollars in thousands)

 

 

 

 

 

 

 

 

 

 

Stock options

 

$

475

 

$

472

 

$

554

Restricted stock awards

 

 

1,850

 

 

857

 

 

553

Stock purchase plan

 

 

144

 

 

114

 

 

80

 

 

$

2,469

 

$

1,443

 

$

1,187

 

Note 16. Stock-Based Compensastion (continued)

Stock options:

A summary of the stock option plans as of December 31, 2019, 2018, and 2017 and changes during the years then ended is presented below:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

December 31, 

 

 

2019

 

2018

 

2017

 

 

 

 

 

Weighted

 

 

 

 

Weighted

 

 

 

 

Weighted

 

 

 

 

 

Average

 

 

 

 

Average

 

 

 

 

Average

 

 

 

 

 

Exercise

 

 

 

 

Exercise

 

 

 

 

Exercise

 

    

Shares

    

Price

    

Shares

    

Price

    

Shares

    

Price

Outstanding, beginning

 

 

469,572

 

$

18.52

 

 

513,554

 

$

17.13

 

 

587,961

 

$

14.83

Granted

 

 

20,200

 

 

36.00

 

 

16,315

 

 

44.02

 

 

43,250

 

 

43.86

Exercised

 

 

(59,393)

 

 

12.11

 

 

(60,127)

 

 

13.56

 

 

(114,100)

 

 

15.12

Forfeited

 

 

(3,466)

 

 

31.59

 

 

(170)

 

 

16.81

 

 

(3,557)

 

 

26.74

Outstanding, ending

 

 

426,913

 

 

20.14

 

 

469,572

 

 

18.52

 

 

513,554

 

 

17.13

 

 

 

  

 

 

  

 

 

  

 

 

  

 

 

  

 

 

  

Exercisable, ending

 

 

365,084

 

 

  

 

 

358,270

 

 

  

 

 

354,269

 

 

  

 

 

 

  

 

 

  

 

 

  

 

 

  

 

 

  

 

 

  

Weighted average fair value per option granted

 

$

11.29

 

 

  

 

$

14.68

 

 

  

 

$

14.75

 

 

  

 

A further summary of options outstanding as of December 31, 2019 is presented below:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Options Outstanding

 

 

 

 

 

 

 

 

 

Weighted

 

 

 

 

Options Exercisable

 

 

 

 

Average

 

Weighted

 

 

 

Weighted

 

 

 

 

Remaining

 

Average

 

 

 

Average

Range of

 

Number

 

Contractual

 

Exercise

 

Number

 

Exercise

Exercise Prices

    

Outstanding

    

Life

    

Price

    

Exercisable

    

Price

$7.99 to $8.93

 

18,405

 

1.11

 

$

8.10

 

18,405

 

$

8.10

$9.00 to $9.30

 

88,490

 

1.47

 

 

9.21

 

88,490

 

 

9.21

$15.50 to $15.65

 

67,541

 

3.24

 

 

15.64

 

66,741

 

 

15.64

$17.10 to $18.00

 

115,645

 

4.56

 

 

17.31

 

114,633

 

 

17.30

$21.71 to $22.64

 

59,905

 

6.08

 

 

22.63

 

46,309

 

 

22.63

$36.00 to $48.50

 

76,927

 

7.91

 

 

41.84

 

30,506

 

 

43.73

 

 

426,913

 

  

 

 

  

 

365,084

 

 

  

 

Restricted stock awards:

A summary of changes in the Company’s nonvested restricted stock, restricted stock unit and performance stock unit awards as of December 31, 2019, 2018 and 2017 is presented below:

 

 

 

 

 

 

 

 

 

 

 

 

December 31, 

 

    

2019

    

2018

    

2017

Outstanding, beginning

 

 

64,099

 

 

46,389

 

 

39,438

Granted*

 

 

85,961

 

 

37,315

 

 

28,289

Released

 

 

(37,624)

 

 

(19,605)

 

 

(21,338)

Forfeited

 

 

(5,610)

 

 

 —

 

 

 —

Outstanding, ending

 

 

106,826

 

 

64,099

 

 

46,389

 

 

 

 

 

 

 

 

 

 

Weighted average fair value per share granted

 

$

20.14

 

$

43.50

 

$

44.44

 

At December 31, 2019, includes 18,634 shares of restricted stock, 49,269 restricted stock units and 18,058 performance share units.

   At December 31, 2018, includes 22,660 shares of restricted stock and 14,655 restricted stock units.

   At December 31, 2017, includes 28,289 shares of restricted stock.

Note 16. Stock-Based Compensation (continued)

The total grant value of restricted stock and restricted stock unit awards that were released during the years ended December 31, 2019, 2018 and 2017 was $1.3 million,  $622 thousand and $509 thousand, respectively.

Stock purchase plan:

The Company’s Board of Directors and its stockholders adopted in October 2002 the QCR Holdings, Inc. Employee Stock Purchase Plan (the “Purchase Plan”). On May 2, 2012, the Company’s stockholders approved a complete amendment and restatement of the Purchase Plan. As of January 1, 2019, there were 128,320 shares of common stock available for issuance under the Purchase Plan. For each six-month offering period, the Board of Directors will determine how many of the total number of available shares will be offered. The purchase price is the lesser of 85% of the fair market value at the date of the grant or the investment date. The investment date, as established by the Board of Directors, is the date common stock is purchased after the end of each calendar quarter during an offering period. The maximum dollar amount any one participant can elect to contribute in an offering period is $10 thousand. Additionally, the maximum percentage that any one participant can elect to contribute is 15% of his or her compensation for the year ended December 31, 2019.  The maximum percentage that any one participant could elect to contributes was 10% of his or her compensation for the years ended December 31, 2018 and 2017. Information for the stock purchase plan for the years ended December 31, 2019, 2018, and 2017 is presented below:

 

 

 

 

 

 

 

 

 

 

 

    

2019

    

2018

    

2017

Shares granted

 

 

29,882

 

 

17,305

 

 

12,414

Shares purchased

 

 

28,775

 

 

15,528

 

 

13,318

Weighted average fair value per share granted

 

$

4.81

 

$

6.63

 

$

6.42